# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2611-2620 of 2745 results.
A Study Of PF-06664178 In Patients With Advanced Solid Tumors
Status: Terminated
Last Changed: Feb 19, 2018
First Received: Apr 24, 2014
Disease(s): Neoplasms
Intervention(s): PF-06664178, PF-06664178
Locations: Keck Hospital of USC, Los Angeles, California, United States
LAC&USC Medical Center, Los Angeles, California, United States
USC/Norris Comprehensive Cancer Center / Investigational Drug Services, Los Angeles, California, United States
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Anschutz Cancer Pavilion, Aurora, Colorado, United States
... and 6 other locations.
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer
Status: Not yet recruiting
Last Changed: Apr 13, 2020
First Received: Jul 28, 2014
Disease(s): Cancer, Overall Survival
Intervention(s): Metabolic treatment
Locations: Care Oncology Clinic, London, United Kingdom
LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)
Status: Completed
Last Changed: Jul 18, 2019
First Received: Jul 11, 2014
Disease(s): Tumors With CDK4/6 Pathway Activation
Intervention(s): LEE011
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
Alaska Clinical Research, Anchorage, Alaska, United States
Arizona Oncology Associates Dept. Of Onc., Phoenix, Arizona, United States
University of Arkansas/ Arkansas Cancer Research Center UA Medical Sciences, Little Rock, Arkansas, United States
PCR Oncology, Pismo Beach, California, United States
... and 57 other locations.
Study of Continuous OSI-906 Dosing
Status: Completed
Last Changed: Jan 14, 2019
First Received: Aug 09, 2007
Disease(s): Advanced Solid Tumors
Intervention(s): OSI-906
Locations: Vanderbilt Universtiy Medical Center, Nashville, Tennessee, United States
The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
Status: Completed
Last Changed: Apr 26, 2011
First Received: Mar 07, 2003
Disease(s): Cancer
Intervention(s): PV701
Locations: Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)
Status: Completed
Last Changed: Jan 29, 2020
First Received: Jan 21, 2013
Disease(s): Solid Tumors
Intervention(s): Avelumab
Locations: Cancer Treatment Centers of America - Western Regional Medical Center, Goodyear, Arizona, United States
Scottsdale Healthcare Corporation, Scottsdale, Arizona, United States
Pinnacle Oncology Hematology, Scottsdale, Arizona, United States
Highlands Oncology Group, Rogers, Arkansas, United States
Pacific Cancer Medical Center, Inc., Anaheim, California, United States
... and 70 other locations.
Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib
Status: Completed
Last Changed: Mar 20, 2017
First Received: Apr 15, 2013
Disease(s): Tumor Pathway Activations Inhibited by Dovitinib
Intervention(s): Dovitinib (TKI258)
Locations: Alabama Oncology, Birmingham, Alabama, United States
Highlands Oncology Group SC, Fayetteville, Arkansas, United States
PCR Oncology, Pismo Beach, California, United States
Sarcoma Oncology Center, Santa Monica, California, United States
Rocky Mountain Cancer Centers Rocky Mountain Cancer Centers, Greenwood Village, Colorado, United States
... and 45 other locations.
MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment
Status: Completed
Last Changed: Nov 27, 2019
First Received: Jan 17, 2013
Disease(s): Solid Tumors, ER/PR Positive Breast Cancer, Triple Negative Breast Cancer, Metastatic Breast Cancer With Active Brain Metastasis
Intervention(s): Ferumoxytol, MM-398
Locations: Mayo Clinic, Scottsdale, Arizona, United States
HonorHealth, Scottsdale, Arizona, United States
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
University of Michighan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
... and 3 other locations.
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
Status: Completed
Last Changed: Jun 27, 2016
First Received: Jul 30, 2009
Disease(s): Advanced Malignancies
Intervention(s): CDX-1401 in combination with Resiquimod and/or Poly-ICLC, CDX-1401, Resiquimod, poly-ICLC
Locations: Yale Comprehensive Cancer Center, New Haven, Connecticut, United States
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
Henry Ford Health System, Detroit, Michigan, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Weill Cornell Cancer Center, New York, New York, United States
... and 3 other locations.
Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned
Status: Completed
Last Changed: Feb 26, 2015
First Received: Dec 20, 2011
Disease(s): Cancer
Intervention(s): I-131-CLR1404
Locations: City of Hope National Medical Center, Duarte, California, United States
Georgetown University Hospital, Washington, DC, District of Columbia, United States
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States